Glycorex Transplantation AB (publ) reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported sales was SEK 6.35 million compared to SEK 8.86 million a year ago. Revenue was SEK 5.59 million compared to SEK 9.93 million a year ago. Net loss was SEK 5.48 million compared to SEK 0.823 million a year ago. Basic loss per share from continuing operations was SEK 0.07 compared to SEK 0.01 a year ago.
For the nine months, sales was SEK 22.79 million compared to SEK 27.75 million a year ago. Revenue was SEK 24.08 million compared to SEK 28.98 million a year ago. Net loss was SEK 13.75 million compared to SEK 6.64 million a year ago. Basic loss per share from continuing operations was SEK 0.19 compared to SEK 0.09 a year ago.